Given the association of lactic acidosis pathway activity with favorable clinical outcomes, understanding the mechanism by which lactic acidosis inhibits Akt and glycolysis may lead to novel therapeutic strategies to modify tumor behavior. This evidence concerns the gene AKT1 and lactic acidosis.